BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 9852274)

  • 1. Analysis of the DNA content in Bowen's disease.
    Korabiowska M; Brinck U; Ruschenburg I; Kellner S; Droese M; Berger H
    Int J Mol Med; 1998 Mar; 1(3):613-6. PubMed ID: 9852274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the DNA content in the different steps of cutaneous carcinoma progression.
    Korabiowska M; Berger H; Keci A; Nagel H; Ruschenburg I; Droese M; Brinck U
    In Vivo; 1999; 13(6):553-7. PubMed ID: 10757054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bowenoid papulosis. Classification as a low-grade in situ carcinoma of the epidermis on the basis of histomorphologic and DNA ploidy studies.
    Böcking A; Chatelain R; Salterberg A; Hagedorn M; Gross G
    Anal Quant Cytol Histol; 1989 Dec; 11(6):419-25. PubMed ID: 2604822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High frequency of DNA aneuploidy detected by DNA flow cytometry in Bowen's disease.
    Kawara S; Takata M; Takehara K
    J Dermatol Sci; 1999 Sep; 21(1):23-6. PubMed ID: 10468188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In situ localization of S-phase-specific histone (H3) mRNA in Bowen's disease.
    Murakami M; Mizoguchi Y; Horibe Y; Komori K; Hori H; Kasahara M
    APMIS; 1999 Nov; 107(11):1005-12. PubMed ID: 10598872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression of keratin 16 in normal and lesional skin of solitary and multiple Bowen's disease using monoclonal antibody Ks 8.12 staining].
    Sheu HM; Ko SS; Yu HS
    J Formos Med Assoc; 1991 Dec; 90(12):1252-5. PubMed ID: 1724782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aneuploidy in actinic keratosis and Bowen's disease--increased risk for invasive squamous cell carcinoma?
    Biesterfeld S; Pennings K; Grussendorf-Conen EI; Böcking A
    Br J Dermatol; 1995 Oct; 133(4):557-60. PubMed ID: 7577583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of p2lWaf1/Cip1 immunohistochemical staining in Bowen's disease, but not in disseminated superficial porokeratosis.
    Kawakami T; Saito R; Takahashi K
    Br J Dermatol; 1999 Oct; 141(4):647-51. PubMed ID: 10583111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of p53, p21(Waf1/Cip1) and TGF-beta(3) immunohistochemical staining in Bowen's disease.
    Kawakami T; Soma Y; Mizoguchi M; Saito R
    Dermatology; 2001; 202(1):9-15. PubMed ID: 11244221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of p16 and pRb expression with HPV detection in Bowen's disease.
    Willman JH; Heinz D; Golitz LE; Shroyer KR
    J Cutan Pathol; 2006 Sep; 33(9):629-33. PubMed ID: 16965338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of EGF receptor expressing and DNA replicating epidermal cells in psoriasis vulgaris and Bowen's disease.
    Amagai M; Ozawa S; Ueda M; Nishikawa T; Abe O; Shimizu N
    Br J Dermatol; 1988 Nov; 119(5):661-8. PubMed ID: 3207620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [DNA determination by cytophotometry in bowenoid papules in comparison with condylomata acuminata and Bowen's disease].
    Gründer K; Nilles M
    Z Hautkr; 1990 Dec; 65(12):1135-8. PubMed ID: 2087843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nestin expression in Bowen's disease and Bowen's carcinoma associated with human papillomavirus.
    Mii S; Amoh Y; Tanabe K; Kitasato H; Sato Y; Katsuoka K
    Eur J Dermatol; 2011; 21(4):515-9. PubMed ID: 21700534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ki-67 and p53 expression in cutaneous Bowen's disease: an immunohistochemical study of fixed-embedded tissue sections.
    Szekeres G; De Giacomoni P
    Acta Derm Venereol; 1994 Mar; 74(2):95-7. PubMed ID: 7911636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of basal cell keratin 14 expression in Bowen's disease: a possible marker for tumour progression.
    Komine M; Okinaga M; Takeda F; Nashiro K; Kikuchi K; Murakami T; Soma Y; Tamaki K
    Br J Dermatol; 2001 Aug; 145(2):223-8. PubMed ID: 11531783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutant p53 protein is expressed in Bowen's disease.
    Sim CS; Slater SD; McKee PH
    Am J Dermatopathol; 1992 Jun; 14(3):195-9. PubMed ID: 1510215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-melanoma skin cancer: an overindulged circumlocution articulating keratinocytic cancer.
    Ruocco V; Ruocco E; Brunetti G; Schwartz RA
    Int J Dermatol; 2014 Mar; 53(3):e228-9. PubMed ID: 23565967
    [No Abstract]   [Full Text] [Related]  

  • 18. Dermoscopic classification of Bowen's disease.
    Payapvipapong K; Tanaka M
    Australas J Dermatol; 2015 Feb; 56(1):32-5. PubMed ID: 25330999
    [No Abstract]   [Full Text] [Related]  

  • 19. Cyclin A and beta-catenin expression in actinic keratosis, Bowen's disease and invasive squamous cell carcinoma of the skin.
    Brasanac D; Boricic I; Todorovic V; Tomanovic N; Radojevic S
    Br J Dermatol; 2005 Dec; 153(6):1166-75. PubMed ID: 16307653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of L-type amino acid transporter 1 in various skin lesions.
    Hirano K; Uno K; Kuwabara H; Kojima K; Ohno S; Sakurai H; Kamma H; Kurata A
    Pathol Res Pract; 2014 Oct; 210(10):634-9. PubMed ID: 24939142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.